全身性エリテマトーデス用グルココルチコイドの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Glucocorticoid for Systemic Lupus Erythematosus Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C2562
• 出版社/出版日：GlobalInfoResearch / 2019年8月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、138ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、全身性エリテマトーデス用グルココルチコイドの世界市場について調べ、まとめました。種類別セグメントは、ヒドロコルチゾン、プレドニソン、プレドニゾロン、トリアムシノロンアセトニド、デキサメタゾン、ベタメタゾン、その他等、用途別セグメントは、油性液体、水性液体、その他等に区分しました。全身性エリテマトーデス用グルココルチコイドの世界市場概観、企業動向、企業別全身性エリテマトーデス用グルココルチコイドシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・全身性エリテマトーデス用グルココルチコイドの市場概観
・全身性エリテマトーデス用グルココルチコイドの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・全身性エリテマトーデス用グルココルチコイドの企業別販売動向、市場シェア、市場集中度、競争動向
・全身性エリテマトーデス用グルココルチコイドの世界市場規模
・全身性エリテマトーデス用グルココルチコイドの北米市場分析（アメリカ、カナダ、メキシコ等）
・全身性エリテマトーデス用グルココルチコイドのアメリカ市場規模推移
・全身性エリテマトーデス用グルココルチコイドのカナダ市場規模推移
・全身性エリテマトーデス用グルココルチコイドのメキシコ市場規模推移
・全身性エリテマトーデス用グルココルチコイドのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・全身性エリテマトーデス用グルココルチコイドのドイツ市場規模推移
・全身性エリテマトーデス用グルココルチコイドのイギリス市場規模推移
・全身性エリテマトーデス用グルココルチコイドのロシア市場規模推移
・全身性エリテマトーデス用グルココルチコイドのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・全身性エリテマトーデス用グルココルチコイドの日本市場規模推移
・全身性エリテマトーデス用グルココルチコイドの中国市場規模推移
・全身性エリテマトーデス用グルココルチコイドの韓国市場規模推移
・全身性エリテマトーデス用グルココルチコイドのインド市場規模推移
・全身性エリテマトーデス用グルココルチコイドの東南アジア市場規模推移
・全身性エリテマトーデス用グルココルチコイドの南米市場分析（ブラジル、アルゼンチン等）
・全身性エリテマトーデス用グルココルチコイドの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・全身性エリテマトーデス用グルココルチコイドの種類別分析/販売量、売上、市場シェア（ヒドロコルチゾン、プレドニソン、プレドニゾロン、トリアムシノロンアセトニド、デキサメタゾン、ベタメタゾン、その他）
・全身性エリテマトーデス用グルココルチコイドの用途別分析/市場規模（油性液体、水性液体、その他）
・全身性エリテマトーデス用グルココルチコイドの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・全身性エリテマトーデス用グルココルチコイドの販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Glucocorticoid for Systemic Lupus Erythematosus market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glucocorticoid for Systemic Lupus Erythematosus.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Glucocorticoid for Systemic Lupus Erythematosus market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glucocorticoid for Systemic Lupus Erythematosus market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Sanofi
Teva
Akorn
GSK
Bausch and Lomb
Bayer Pharmas
Fougera Pharms
Hikma Intl Pharms
Impax Labs
Lannett
Merck
Novartis
Sandoz
TARO
Valeant
Wockhardt
Solvay Pharma
Alcon
Paladin Labs
Adcock Ingram
ADARE Pharmaceuticals
Aspen Holdings
Astellas Pharma
Endo International
Sun Pharmaceutical
Perrigo
Aerosol

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Hydrocortisone
Prednison
Prednisolone
Triamcinolone Acetonide
Dexamethasone
Betamethasone
Other

Market Segment by Applications, can be divided into
Hospital
Clinic
Pharmacy
Other

レポート目次

Table of Contents

1 Glucocorticoid for Systemic Lupus Erythematosus Market Overview
1.1 Product Overview and Scope of Glucocorticoid for Systemic Lupus Erythematosus
1.2 Classification of Glucocorticoid for Systemic Lupus Erythematosus by Types
1.2.1 Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Comparison by Types (2019-2024)
1.2.2 Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Types in 2018
1.2.3 Hydrocortisone
1.2.4 Prednison
1.2.5 Prednisolone
1.2.6 Triamcinolone Acetonide
1.2.7 Dexamethasone
1.2.8 Betamethasone
1.2.9 Other
1.3 Global Glucocorticoid for Systemic Lupus Erythematosus Market by Application
1.3.1 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Glucocorticoid for Systemic Lupus Erythematosus Market by Regions
1.4.1 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Glucocorticoid for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Glucocorticoid for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Glucocorticoid for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Glucocorticoid for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Glucocorticoid for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.5 Global Market Size of Glucocorticoid for Systemic Lupus Erythematosus (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva
2.3.1 Business Overview
2.3.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.4 Akorn
2.4.1 Business Overview
2.4.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Akorn Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.5 GSK
2.5.1 Business Overview
2.5.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GSK Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bausch and Lomb
2.6.1 Business Overview
2.6.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bausch and Lomb Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bayer Pharmas
2.7.1 Business Overview
2.7.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bayer Pharmas Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.8 Fougera Pharms
2.8.1 Business Overview
2.8.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Fougera Pharms Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hikma Intl Pharms
2.9.1 Business Overview
2.9.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hikma Intl Pharms Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.10 Impax Labs
2.10.1 Business Overview
2.10.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Impax Labs Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.11 Lannett
2.11.1 Business Overview
2.11.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Lannett Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.12 Merck
2.12.1 Business Overview
2.12.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.13 Novartis
2.13.1 Business Overview
2.13.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Novartis Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.14 Sandoz
2.14.1 Business Overview
2.14.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Sandoz Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.15 TARO
2.15.1 Business Overview
2.15.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 TARO Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.16 Valeant
2.16.1 Business Overview
2.16.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Valeant Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.17 Wockhardt
2.17.1 Business Overview
2.17.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Wockhardt Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.18 Solvay Pharma
2.18.1 Business Overview
2.18.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Solvay Pharma Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.19 Alcon
2.19.1 Business Overview
2.19.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Alcon Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.20 Paladin Labs
2.20.1 Business Overview
2.20.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Paladin Labs Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.21 Adcock Ingram
2.21.1 Business Overview
2.2.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Adcock Ingram Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.22 ADARE Pharmaceuticals
2.22.1 Business Overview
2.22.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 ADARE Pharmaceuticals Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.23 Aspen Holdings
2.23.1 Business Overview
2.23.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Aspen Holdings Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.24 Astellas Pharma
2.24.1 Business Overview
2.24.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Astellas Pharma Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.25 Endo International
2.25.1 Business Overview
2.25.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Endo International Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.26 Sun Pharmaceutical
2.26.1 Business Overview
2.26.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Sun Pharmaceutical Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.27 Perrigo
2.27.1 Business Overview
2.27.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Perrigo Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.28 Aerosol
2.28.1 Business Overview
2.28.2 Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Aerosol Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
3 Global Glucocorticoid for Systemic Lupus Erythematosus Market Competition, by Players
3.1 Global Glucocorticoid for Systemic Lupus Erythematosus Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Glucocorticoid for Systemic Lupus Erythematosus Players Market Share
3.2.2 Top 10 Glucocorticoid for Systemic Lupus Erythematosus Players Market Share
3.3 Market Competition Trend
4 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size by Regions
4.1 Global Glucocorticoid for Systemic Lupus Erythematosus Revenue and Market Share by Regions
4.2 North America Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.3 Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.5 South America Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
5 North America Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries
5.1 North America Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
5.2 USA Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
5.3 Canada Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
5.4 Mexico Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6 Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries
6.1 Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
6.2 Germany Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.3 UK Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.4 France Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.5 Russia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.6 Italy Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries
7.1 Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
7.2 China Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.3 Japan Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.4 Korea Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.5 India Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
8 South America Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries
8.1 South America Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
8.2 Brazil Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
8.3 Argentina Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
8.4 Colombia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Glucocorticoid for Systemic Lupus Erythematosus by Countries
9.1 Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
9.2 Saudi Arabia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.3 UAE Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.4 Egypt Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.5 Nigeria Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.6 South Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
10 Global Glucocorticoid for Systemic Lupus Erythematosus Market Segment by Type
10.1 Global Glucocorticoid for Systemic Lupus Erythematosus Revenue and Market Share by Type (2014-2019)
10.2 Global Glucocorticoid for Systemic Lupus Erythematosus Market Forecast by Type (2019-2024)
10.3 Hydrocortisone Revenue Growth Rate (2014-2024)
10.4 Prednison Revenue Growth Rate (2014-2024)
10.5 Prednisolone Revenue Growth Rate (2014-2024)
10.6 Triamcinolone Acetonide Revenue Growth Rate (2014-2024)
10.7 Dexamethasone Revenue Growth Rate (2014-2024)
10.8 Betamethasone Revenue Growth Rate (2014-2024)
10.9 Other Revenue Growth Rate (2014-2024)
11 Global Glucocorticoid for Systemic Lupus Erythematosus Market Segment by Application
11.1 Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Application (2014-2019)
11.2 Glucocorticoid for Systemic Lupus Erythematosus Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Pharmacy Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Forecast (2019-2024)
12.1 Global Glucocorticoid for Systemic Lupus Erythematosus Market Size Forecast (2019-2024)
12.2 Global Glucocorticoid for Systemic Lupus Erythematosus Market Forecast by Regions (2019-2024)
12.3 North America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.4 Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.6 South America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Glucocorticoid for Systemic Lupus Erythematosus Picture
Table Product Specifications of Glucocorticoid for Systemic Lupus Erythematosus
Table Global Glucocorticoid for Systemic Lupus Erythematosus and Revenue (Million USD) Market Split by Product Type
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Types in 2018
Figure Hydrocortisone Picture
Figure Prednison Picture
Figure Prednisolone Picture
Figure Triamcinolone Acetonide Picture
Figure Dexamethasone Picture
Figure Betamethasone Picture
Figure Other Picture
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) by Application (2014-2024)
Figure Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Pharmacy Picture
Figure Other Picture
Table Global Market Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Pfizer Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Sanofi Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Teva Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Akorn Basic Information, Manufacturing Base and Competitors
Table Akorn Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Akorn Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table GSK Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch and Lomb Basic Information, Manufacturing Base and Competitors
Table Bausch and Lomb Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Bausch and Lomb Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Pharmas Basic Information, Manufacturing Base and Competitors
Table Bayer Pharmas Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Bayer Pharmas Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Fougera Pharms Basic Information, Manufacturing Base and Competitors
Table Fougera Pharms Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Fougera Pharms Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Intl Pharms Basic Information, Manufacturing Base and Competitors
Table Hikma Intl Pharms Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Hikma Intl Pharms Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Labs Basic Information, Manufacturing Base and Competitors
Table Impax Labs Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Impax Labs Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Lannett Basic Information, Manufacturing Base and Competitors
Table Lannett Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Lannett Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Merck Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Novartis Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Sandoz Basic Information, Manufacturing Base and Competitors
Table Sandoz Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Sandoz Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table TARO Basic Information, Manufacturing Base and Competitors
Table TARO Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table TARO Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Valeant Basic Information, Manufacturing Base and Competitors
Table Valeant Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Valeant Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Wockhardt Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Solvay Pharma Basic Information, Manufacturing Base and Competitors
Table Solvay Pharma Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Solvay Pharma Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Alcon Basic Information, Manufacturing Base and Competitors
Table Alcon Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Alcon Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Paladin Labs Basic Information, Manufacturing Base and Competitors
Table Paladin Labs Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Paladin Labs Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Adcock Ingram Basic Information, Manufacturing Base and Competitors
Table Adcock Ingram Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Adcock Ingram Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table ADARE Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table ADARE Pharmaceuticals Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table ADARE Pharmaceuticals Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Aspen Holdings Basic Information, Manufacturing Base and Competitors
Table Aspen Holdings Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Aspen Holdings Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Astellas Pharma Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Endo International Basic Information, Manufacturing Base and Competitors
Table Endo International Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Endo International Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Sun Pharmaceutical Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Perrigo Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Aerosol Basic Information, Manufacturing Base and Competitors
Table Aerosol Glucocorticoid for Systemic Lupus Erythematosus Type and Applications
Table Aerosol Glucocorticoid for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) by Players (2014-2019)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Players (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Players in 2017
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Players in 2018
Figure Global Top 5 Players Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share in 2018
Figure Global Top 10 Players Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share in 2018
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) by Regions (2014-2019)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Regions (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Regions (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Regions in 2018
Figure North America Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure South America Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table North America Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
Table North America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure North America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure North America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure USA Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Canada Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Mexico Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) by Countries (2014-2019)
Figure Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure Germany Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure UK Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure France Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Russia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Italy Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure China Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Japan Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Korea Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure India Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table South America Glucocorticoid for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
Table South America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure South America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure South America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure Brazil Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Argentina Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Colombia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure Saudi Arabia Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure UAE Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Egypt Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Nigeria Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure South Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) by Type (2014-2019)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Type (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Type (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Type in 2018
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Forecast by Type (2019-2024)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Market Share Forecast by Type (2019-2024)
Figure Global Hydrocortisone Revenue Growth Rate (2014-2019)
Figure Global Prednison Revenue Growth Rate (2014-2019)
Figure Global Prednisolone Revenue Growth Rate (2014-2019)
Figure Global Triamcinolone Acetonide Revenue Growth Rate (2014-2019)
Figure Global Dexamethasone Revenue Growth Rate (2014-2019)
Figure Global Betamethasone Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue by Application (2014-2019)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Application (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Application (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Share by Application in 2018
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Forecast by Application (2019-2024)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Glucocorticoid for Systemic Lupus Erythematosus Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure Europe Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure South America Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Glucocorticoid for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)

Global Biologicals for Systemic Lupus Erythematosus Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C0781 2019年8月 105Pages
本調査レポートは、全身性エリテマトーデス生物製剤の世界市場について調べ、まとめました。種類別セグメントは、リツキシマブ、ベリムマブ、アニフロルマブ、UBP-1213、その他等、用途別セグメントは、商業用途、家族用途、実験室用途、その他等に区分しました。全身性エリテマトーデス生物製剤の世界市場概観、企...

全身性硬化症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Systemic Sclerosis Treatments Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5645 2019年7月 101Pages
本調査レポートは、全身性硬化症治療の世界市場について調べ、まとめました。種類別セグメントは、限局性皮膚全身性硬化症、びまん性皮膚全身性硬化症等、用途別セグメントは、等に区分しました。全身性硬化症治療の世界市場概観、企業動向、企業別全身性硬化症治療シェア、市場規模推移、市場規模予測（2019年-202...

皮膚・全身性リーシュマニア症薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Cutaneous and Systemic Leishmaniasis Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1569 2019年7月 116Pages
本調査レポートは、皮膚・全身性リーシュマニア症薬の世界市場について調べ、まとめました。種類別セグメントは、5価アンチモン薬、抗真菌薬、抗リーシュマニア薬/抗菌薬等、用途別セグメントは、等に区分しました。皮膚・全身性リーシュマニア症薬の世界市場概観、企業動向、企業別皮膚・全身性リーシュマニア症薬シェア...

リウマチ性障害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Rheumatic Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4953 2019年7月 107Pages
本調査レポートは、リウマチ性障害薬の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、等に区分しました。リウマチ性障害薬の世界市場概観、企業動向、企業別リウマチ性障害薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等...

プレドニゾロンの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Prednisolone Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4686 2019年8月 137Pages
本調査レポートは、プレドニゾロンの世界市場について調べ、まとめました。種類別セグメントは、表、経口薬等、用途別セグメントは、組織培養・組織工学、ワクチン製造、遺伝子治療と再生医療、毒性試験と薬物スクリーニング、癌研究、出生前診断、幹細胞治療、等に区分しました。プレドニゾロンの世界市場概観、企業動向、...

世界のループス腎炎市場：市場規模・現状・予測

Global Lupus Nephritis Market Size, Status and Forecast 2019-2025
QYR9N7486 2019年6月14日 98Pages
当資料は、ループス腎炎のグローバル市場について調査・分析したレポートで、種類別（診断、薬）、用途別（病院、診療所、外来手術センター、製薬会社）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

...

世界の全身性アスペルギルス症と全身性カンジダ症市場2019

Global Systemic Aspergillosis and Systemic Candidasis Sales Market Report 2019
QYR9N4912 2019年6月14日 100Pages
本調査レポートでは、全身性アスペルギルス症と全身性カンジダ症の世界市場について調査・分析し、全身性アスペルギルス症と全身性カンジダ症のメーカー別販売量、市場シェア分析、種類別販売分析（ボリコナゾール、リポソームアムホテリシンB、全身口腔アゾール、局所抗真菌剤、その他）、用途別販売分析（CPA、ABP...

世界の全身口腔アゾール市場2019

Global Systemic Oral Azoles Sales Market Report 2019
QYR9N4914 2019年6月14日 101Pages
本調査レポートでは、全身口腔アゾールの世界市場について調査・分析し、全身口腔アゾールのメーカー別販売量、市場シェア分析、種類別販売分析（フルコナゾール、イトラコナゾール、ポサコナゾール）、用途別販売分析（消化管カンジダ症、尿生殖路カンジダ症、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東...

世界の全身性肥満細胞症の治療市場2019

Global Systemic Mastocytosis Treatment Sales Market Report 2019
QYR9N4913 2019年6月14日 105Pages
本調査レポートでは、全身性肥満細胞症の治療の世界市場について調査・分析し、全身性肥満細胞症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（AK-002、BLU-285、ブレントキシマブベドチン、クレノラニブベシレート、クロモリンナトリウム、その他）、用途別販売分析（診療所、病院、在宅ケア）...

全身型口腔アゾール市場：世界及び中国市場分析・予測（～2024年）

Systemic Oral Azoles Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J03461 2019年7月 146Pages
世界及び中国における全身型口腔アゾール市場について調査・分析したレポートで、全身型口腔アゾールの世界市場動向、市場規模、主要企業情報などが含まれています。全身型口腔アゾールの種類別には、フルコナゾール、イトラコナゾール、ポサコナゾールに分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに...

全身性エリテマトーデス生物製剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Biologicals for Systemic Lupus Erythematosus market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, e…
プレドニゾロンの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Prednisolone market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast gr…
世界のループス腎炎市場：市場規模・現状・予測 Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. Whil…
世界の全身性アスペルギルス症と全身性カンジダ症市場2019 The global Systemic Aspergillosis and Systemic Candidasis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Systemic Aspergillosis and Systemic Candidasis market status and forecast, categoriz…
全身性硬化症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Systemic sclerosis is a rare but serious autoimmune disease which causes hardening and swelling of the skin, as well as joint pain, digestive problems, lung disease, and sometimes problems with the heart and kidneys. Scope of the Report: The global Systemic Sclerosis Treatments market is valued at x…